Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Russia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20062
20071
20082
20096
20102
20111
20122
20132
20151
20162
20171
20181
20191
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting4
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Eli Lilly and Company2
GlaxoSmithKline2
Institut de Recherches Internationales Servier2
Pfizer2
AbbVie1
Ascenta Therapeutics1
Astellas Pharma Inc1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis30
Neoplasms9
Breast Neoplasms8
Colorectal Neoplasms6
Adenocarcinoma3
Recurrence3
Carcinoma, Non-Small-Cell Lung2
Colonic Neoplasms2
Rectal Neoplasms2
Adenocarcinoma of Lung1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.